Announcements

Announcements

 
AERAS  [to 7 Jul 2018]
http://www.aeras.org/pressreleases
No new digest content identified.
 
 
BMGF – Gates Foundation  [to 7 Jul 2018]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute    [to 7 Jul 2018]
https://www.linkedin.com/company/bill-melinda-gates-medical-research-institute/
   The Bill & Melinda Gates Medical Research Institute is a non-profit research organization dedicated to combating diseases that impact the world’s poorest. We strive to combat inequities in health by accelerating progress in translational science to ensure life-saving products are available and accessible to everyone. We consider ourselves pioneers dedicated to uncovering radical solutions that will close the gap between cutting-edge scientific innovation and its application to challenges in global health.
No new digest content identified..

 

CARB-X   [to 7 Jul 2018]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 7 Jul 2018]
http://cepi.net/
No new digest content identified.

 

EDCTP    [to 7 Jul 2018]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
7 July 2018
African countries to assess their health research systems
In partnership with the Ghanaian Health Service, EDCTP will organise the kick-off meeting (Accra, 9-10 July 2018) for a project to assess African health research systems. The main objective of the meeting is to prepare a survey of national health research capacities in the 17 African EDCTP member countries…

4 July 2018
Thirty African scientists funded to conduct implementation research
WHO Regional Office for Africa (WHO AFRO) with TDR (the Special Programme for Research and Training in Tropical Diseases) and EDCTP have announced 30 small grant awarded to scientists from across Africa for implementation research on infectious diseases of poverty. EDCTP’s contribution to this joint investment was directly supported by Germany, Sweden and the United Kingdom…

 

Emory Vaccine Center    [to 7 Jul 2018]
http://www.vaccines.emory.edu/
No new digest content identified.

 

European Medicines Agency  [to 7 Jul 2018]
http://www.ema.europa.eu/ema/
No new digest content identified.
 
 
European Vaccine Initiative  [to 7 Jul 2018]
http://www.euvaccine.eu/news-events
27 June 2018
Registration for EVI 20th Anniversary Symposium now open
On 20/21 November, EVI will celebrate its 20th anniversary with a symposium in Heidelberg, Germany. A draft agenda is now…
 
 
FDA [to 7 Jul 2018]
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
No new digest content identified.
 
 
Fondation Merieux  [to 7 Jul 2018]
http://www.fondation-merieux.org/
No new digest content identified.
 

Gavi [to 7 Jul 2018]
http://www.gavi.org/library/news/press-releases/
No new digest content identified.

 

GHIT Fund   [to 7 Jul 2018]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.

 

Global Fund [to 7 Jul 2018]
http://www.theglobalfund.org/en/news/?topic=&type=NEWS;&country=
No new digest content identified.

 
Hilleman Laboratories   [to 7 Jul 2018]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 7 Jul 2018]
http://www.humanvaccinesproject.org/media/press-releases/
Public Release: 28-Jun-2018
Human Vaccines Project and Seqirus partner to advance universal flu vaccine research
NEW YORK AND MAIDENHEAD, UK, JUNE 28, 2018 – The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the prevention of influenza, announced today that Seqirus is joining the Project’s Universal Influenza Vaccine Initiative (UIVI). Seqirus, owned by CSL Limited, has been on the front line of influenza vaccine development and pandemic preparedness for more than a century, pioneering new technologies for rapidly producing influenza vaccines…
 
 
IAVI  [to 7 Jul 2018]
https://www.iavi.org/
No new digest content identified.
 
 
IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.

 

IVAC  [to 7 Jul 2018]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
No new digest content identified.
 
 
IVI   [to 7 Jul 2018]
http://www.ivi.int/
No new digest content identified.

 
JEE Alliance  [to 7 Jul 2018]
https://www.jeealliance.org/
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 7 Jul 2018]
http://www.msf.org/
Interview   5 July 2018
“We should take every opportunity to vaccinate against deadly diseases”
Interview with Miriam Alía, MSF vaccination and outbreak response advisor, on the outbreaks of meningitis C and measles that have affected Niger in 2018

Project Update  3 July 2018
MSF hands over Ebola response activities in DRC
After a two-month emergency intervention in Equator Province, Democratic Republic of Congo (DRC), we have begun handing over our Ebola response activities to the Congolese Ministry of Health and other non-governmental organisations in Mbandaka, Bikoro, Itipo and Iboko.
“This Ebola outbreak is not yet officially over but we are very pleased with the progress that has been made,” said Henry Gray, MSF emergency coordinator in Equator Province. “Given the low volume of cases and the increasing expertise of local staff, the Ministry of Health is well placed to finish the work we started together.”…

Project Update  3 July 2018
MSF facilitates access to healthcare in communities of San Salvador and Soyapango
Through primary healthcare services, mental health services and community work, Médecins Sans Frontières (MSF) aims to improve access to health services for vulnerable people affected by the ongoing violence.
MSF has launched health initiatives in San Salvador and Soyapango, focusing on socially vulnerable people whose access to health services has been affected by insecurity. MSF is working closely with public health institutions to provide care to the people who need it most, under agreement with the Ministry of Health…
 
 
NIH  [to 7 Jul 2018]
http://www.nih.gov/news-events/news-releases
July 2, 2018
NIH to host workshop on using artificial intelligence and machine learning to advance biomedical research
— Experts from organizations including IBM, Amazon and MIT will discuss the application of these emerging technologies.
When: Monday, July 23, 2018, 8:45 a.m. – 4:40 p.m. EDT
Where: John Edward Porter Neuroscience Research Center, Building 35, Room 620 on the NIH Main Campus, Bethesda, Maryland. Information on visiting Porter can be found here. The summit will also be available to view online via live videocast at: https://videocast.nih.gov/summary.asp?live=28053&bhcp=1
Contact: Registration (link is external) for this workshop is required

 

PATH  [to 7 Jul 2018]
http://www.path.org/news/index.php
No new digest content identified.

 

Sabin Vaccine Institute  [to 7 Jul 2018]
http://www.sabin.org/updates/pressreleases
No new digest content identified.
 
 
UNAIDS [to 7 Jul 2018]
http://www.unaids.org/en
No new digest content identified.

 

UNICEF  [to 7 Jul 2018]
https://www.unicef.org/media/
Selected Press Releases/Reports
No new digest content identified…most recent press release dated 15 May 2018]

 
Vaccine Confidence Project  [to 7 Jul 2018]
http://www.vaccineconfidence.org/
No new digest content identified.
 

Vaccine Education Center – Children’s Hospital of Philadelphia  [to 7 Jul 2018]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
 
Wellcome Trust  [to 7 Jul 2018]
https://wellcome.ac.uk/news
No new digest content identified.
 
 
The Wistar Institute   [to 7 Jul 2018]
https://www.wistar.org/news/press-releases
No new digest content identified.

 

World Organisation for Animal Health (OIE)   [to 7 Jul 2018]
http://www.oie.int/en/for-the-media/press-releases/2018/
No new digest content identified.

::::::
 
BIO    [to 7 Jul 2018]
https://www.bio.org/insights/press-release
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network  [to 7 Jul 2018]
http://www.dcvmn.org/
No new digest content identified.
 
 
IFPMA   [to 7 Jul 2018]
http://www.ifpma.org/resources/news-releases/
No new digest content identified.
 
 
PhRMA    [to 7 Jul 2018]
http://www.phrma.org/press-room
No new digest content identified.

 

Industry Watch    [to 7 Jul 2018]
:: Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China
CHENGDU, China, July 2, 2018 /PRNewswire/ — Sanofi is launching a Global R&D Operations Hub with a specialized focus on digitalization and big data analysis in Chengdu, Sichuan province, China. The new R&D operations hub confirms China as the third pillar of Sanofi Global Clinical Sciences and Operations, joining facilities in France and the United States.
With an investment of €66 million, the Hub will support the clinical research and development of Sanofi’s innovative drugs by focusing on the management of global multi-center clinical trials data and files. Bringing together global data and analysis, the Hub will accelerate the availability of trial results, from Phase I to Phase IV. The Hub will take advantage of local talents to further strengthen Sanofi’s digital capabilities.
The Chengdu Hub will target diseases that affect millions of people across our therapeutic areas: diabetes and cardiovascular diseases, vaccines, oncology, immunology and inflammation, rare diseases, multiple sclerosis and neurology. It will leverage global cutting-edge biological technology for polypeptides, gene therapy, monoclonal antibodies and multi-specific antibodies. The Hub plans to recruit 300 local pharmaceutical research and development professionals by 2020…